Infinion Biopharma Limited is a public company, founded on 16 Jan 2018. This company focuses on innovation that blends biophysics, engineering, classical pharmacology, and biochemistry to generate high-value products across a range of therapeutic areas. A total of 45 lakh equity shares with a face value of Rs. 10 will be sold as part of the Initial public offering.
Purpose of the Issue
To meet working capital requirement
Using this fund to invest in Mobius Biomedical Inc.
Acquire licenses in women’s health products and skin care for product development